A) GLP-1 medications used in our medical weight loss programs work by mimicking the bodys natural GLP-1 hormone
Essential documentation elements include: Confirmed diagnosis of type 2 diabetes mellitus with supporting evidence (HbA1c results, glucose monitoring data) Detailed description of neuropathic symptoms, including location, character, severity, and temporal pattern Findings from neurological examination, particularly sensory testing using 10-g monofilament, vibration perception (128-Hz tuning fork), and ankle reflexes Specification of neuropathy type (e.g., distal symmetric polyneuropathy, autonomic neuropathy, mononeuropathy) Foot risk stratification according to NICE NG19 criteria (low risk, moderate risk, high risk, active diabetic foot problem) Results from diagnostic investigations such as nerve conduction studies when performed for atypical or uncertain cases Documentation of any functional impairment or complications arising from neuropathy Clinicians should avoid vague terminology such as 'possible neuropathy' or 'neuropathic symptoms' without clear diagnostic confirmation
Oral GnRH antagonists such as elagolix induce dose-dependent suppression of LH, FSH, and estradiol levels, reducing pain while minimizing severe hypoestrogenism
"Future directions in peptide research: Emerging applications and methodologies." Peptide Science Advances , 2024
(5) Adverse Effects and Contraindications: The most notable adverse effect is increased blood pressure
